Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
What people know at the time they make decisions about having tests for risk of specific cancers is important if they are to be able to make truly informed decisions about the value of these tests. That becomes even more important when we consider the pros and cons of annual, mass, population-based cancer screening tests.
Filed under: Diagnosis, Risk | Tagged: knowledge, screening, testing | 5 Comments »
There are no recent guidelines regarding the use of PSA tests and digital rectal exams as tests for risk of prostate cancer issued by any of the national organizations representing primary care physicians. However, a new report has provided data about the current behaviors of members of the primary care community at one academic medical center.
Filed under: Diagnosis, Risk | Tagged: knowledge, primary care, prostate specific antigen, PSA, risk, screening, testing | 3 Comments »
As Leah wrote in a comment on this blog just the other day, “Yes, the ‘D-word’ is still taboo. Death is UNAMERICAN.” The comment stimulated the thought that our preconceptions have significant impact on how we think about risk, diagnosis, and treatment of prostate cancer — and yet there is really very little good research on [...]
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: decision-making, knowledge, Management, perception, Treatment | 26 Comments »
A fascinating paper has just been published in BJU International suggesting that, “Higher education, income and functional capacity were associated with” poorer knowledge about their cancer, poorer understanding about treatment choices, and poorer judgement about survival with and without treatment among a group of 184 patients recently diagnosed with localized prostate cancer.
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: education, income, judgment, knowledge, Treatment, understanding | 9 Comments »
Search for new and
ongoing trials on the
CTAG PCa web site